As Georgia’s largest and most comprehensive cancer care provider, the Northside Hospital Cancer Institute (NHCI) Prostate and Urologic Cancer Program diagnoses and/or treats more new prostate cancer patients than any other cancer program in Georgia and we’re ranked among the top 10 prostate cancer programs in the country.
Urologic cancers, which include cancers of the prostate, kidneys, bladder, penis and testicles, are complex diseases for which multiple treatment options exist. Our Prostate and Urologic Cancer Program’s multidisciplinary team of specialists work together utilizing a coordinated team approach to yield higher rates of treatment success.
Prostate cancer is the second most common cancer in American men and will affect one in every nine men. The risk of prostate cancer is 74 percent higher in black men than in white men for reasons that remain unclear. Additionally, this year over 65,000 people will be diagnosed with kidney cancer in the United States. Kidney cancer incidence rates appear to have stabilized since the mid-2000s following decades of increase, in part due to a rise in incidental detection because of the increased use of medical imaging. Bladder cancer is the fourth most common cancer among men and the ninth most common among women in the United States. Bladder cancer incidence is increasing both nationally and here in Georgia. In 2018, nearly 2,000 Georgians will be diagnosed with bladder cancer.
Northside Hospital Cancer Institute’s Prostate and Urologic Cancer Program offers specialized cancer care for patients diagnosed with:
For more information about the prostate and urologic cancers Northside Hospital Cancer Institute treats, please click on a cancer type below.
